Literature DB >> 9519028

MedWatch: FDA's Medical Products Reporting Program.

S A Goldman, D L Kennedy.   

Abstract

Mesh：

Year:  1998        PMID： 9519028     DOI： 10.3810/pgm.1998.03.408

Source DB:  PubMed          Journal:  Postgrad Med        ISSN： 0032-5481            Impact factor:   3.840


× No keyword cloud information.
  5 in total

Review 1.  Manufacturer's drug interaction and postmarketing adverse event data: what are appropriate uses?

Authors:  W K Kraft; S A Waldman
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

2.  Physician response to patient reports of adverse drug effects: implications for patient-targeted adverse effect surveillance.

Authors:  Beatrice A Golomb; John J McGraw; Marcella A Evans; Joel E Dimsdale
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 3.  Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.

Authors:  Beatrice A Golomb; Marcella A Evans
Journal:  Am J Cardiovasc Drugs       Date:  2008       Impact factor: 3.571

4.  Legal regulations of complementary and alternative medicines in different countries.

Authors:  Shailendra Saraf
Journal:  Pharmacogn Rev       Date:  2012-07

5.  Developing a Method for Reporting Patient Harm Due to Antimicrobial Shortages.

Authors:  Milena M McLaughlin; Erik Skoglund; Zachary Pentoney; Marc H Scheetz
Journal:  Infect Dis Ther       Date:  2014-09-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.